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Highlights 
- Acupuncture has a clinically relevant effect on chronic pain that persists over time 
- The effect of acupuncture cannot be explained only by placebo effects 
- Factors in addition to the specific effects of needling are important contributors 
- Referral for acupuncture treatment is a reasonable option for chronic pain patients 
 
Abstract 
Despite wide use in clinical practice, acupuncture remains a controversial treatment for chronic pain. Our objective was 
to update an individual patient data meta-analysis to determine the effect size of acupuncture for four chronic pain 
conditions.We searched MEDLINE and the Cochrane Central Registry of Controlled Trials randomized trials published up 
until December 31, 2015. We included randomized trials of acupuncture needling versus either sham acupuncture or no 
acupuncture control for non-specific musculoskeletal pain, osteoarthritis, chronic headache, or shoulder pain. Trials 
were only included if allocation concealment was unambiguously determined to be adequate. Raw data were obtained 
from study authors and entered into an individual patient data meta-analysis. The main outcome measures were pain 
and function. An additional 13 trials were identified, with data received for a total of 20,827 patients from 39 trials. 
Acupuncture was superior to both sham and no acupuncture control for each pain condition (all p<0.001) with 
differences between groups close to 0.5 standard deviations (SD) for comparison with no acupuncture control and close 
to 0.2 SDs in comparison with sham. We also found clear evidence that the effects of acupuncture persist over time with 
only a small decrease, approximately 15%, in treatment effect at one year. In secondary analyses, we found no obvious 
association between trial outcome and characteristics of acupuncture treatment, but effect sizes of acupuncture were 
associated with the type of control group, with smaller effects sizes for sham controlled trials that used a penetrating 
needle for sham, and for trials that had high intensity of intervention in the control arm.We conclude that acupuncture 
is effective for the treatment of chronic pain, with treatment effects persisting over time. While factors in addition to 
the specific effects of needling at correct acupuncture point locations are important contributors to the treatment 
effect, decreases in pain following acupuncture cannot be explained solely in terms of placebo effects. Variations in the 
effect size of acupuncture in different trials are driven predominately by differences in treatments received by the 
control group rather than by differences in the characteristics of acupuncture treatment. 
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Perspective 
Acupuncture is effective for the treatment of chronic musculosketal, headache and osteoarthritis pain. Treatment 
effects of acupuncture persist over time and cannot be explained solely in terms of placebo effects. Referral for a course 
of acupuncture treatment is a reasonable option for a patient with chronic pain. 
Keywords: Acupuncture, chronic pain, meta-analysis, osteoarthritis, back pain, neck pain, migraine, tension-type 
headaches, shoulder pain 
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Introduction 
Acupuncture remains a controversial treatment for chronic pain, largely due to a provenance outside biomedicine. 
Traditional acupuncture theory invokes non-anatomical structures such as meridians and non-physiological processes 
such as the flow of qi energy. Although many contemporary practitioners do not rely on such concepts, there remains a 
dearth of data on how insertion of needles at specific points on the body could lead to long-term decreases in pain. 
Acupuncture undoubtedly has short-term physiological effects, several of which are relevant to pain7, 76, 119, but there is 
as yet no explanation as to how such effects could persist. 
We previously reported an individual patient data meta-analysis of high-quality trials of acupuncture for chronic pain.92 
Differences between acupuncture and control in trials without sham (placebo) control were both statistically and 
clinically significant. Acupuncture was significantly superior to sham control, suggesting that acupuncture effects are not 
solely explicable in terms of placebo, although these differences were relatively modest. We have separately reported 
secondary analyses examining whether characteristics of acupuncture treatment65 or control groups68 influence effect 
size, and whether the effects of acupuncture treatment persist over time69. Here we update our prior analyses now 
including studies published during the last 7 years.  
Methods 
The full protocol of the meta-analysis93 and the results of the first individual patient data meta-analysis including RCTs 
published up to November 200892 have been published. The literature search was repeated to identify eligible RCTs 
published between December 2008 and December 2015. Trials were considered eligible if they accrued patients with 
nonspecific back or neck pain, shoulder pain, chronic headache, or osteoarthritis; pain duration was at least 4 weeks for 
musculoskeletal disorders; at least one group received acupuncture needling and one group received either sham 
acupuncture or no acupuncture control; the primary endpoint was measured more than 4 weeks after the initial 
acupuncture treatment; and allocation concealment was determined unambiguously to be adequate. Principal 
investigators of eligible studies were asked to provide raw data. These raw data were used to replicate all analyses 
published in the original RCT publication to ensure data accuracy. Each trial was reanalyzed by analysis of covariance 
with the standardized primary endpoint (scores divided by pooled standard deviation) as the dependent variable, and 
the baseline measure of the primary endpoint and variables used to stratify randomization as covariates. The primary 
outcome for each study was that identified by the responding author of each study. The effect sizes for each study were 
then entered into a meta-analysis using the metan command in Stata (version 13, StataCorp, College Station, TX). Both 
fixed effects and random effects estimates were calculated. Fixed effects weights were calculated using inverse-variance 
weighting, and random effects weights were calculated using the DerSimonian and Laird method. We pre-specified that 
meta-analyses would be conducted separately for comparisons of acupuncture vs. sham and acupuncture vs. no 
acupuncture control, and within each pain type, and the hypothesis test would be based on the fixed effects analysis. In 
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the original paper, trials for which individual patient data were not available were included as a sensitivity analysis; in 
this update, we include summary data for these trials in the main meta-analysis and exclude them as a sensitivity 
analysis. 
As secondary analyses, we examined whether characteristics of acupuncture treatment modified treatment effects. 
Both trial-level and patient-level analyses were performed. For trial-level analyses, we used random-effects meta-
regression to test the effect of each characteristic on the main effect estimate using the Stata command metareg. For 
patient-level analyses, we created a linear regression as for the main analysis of effect size, but included the 
characteristic and an interaction term between the characteristic and treatment allocation. The coefficient was then 
entered into a meta-analysis. In both analyses, random effects estimates and 95% confidence intervals were reported; p 
values are based on the fixed effects analysis. We also analyzed the effect of acupuncture relative to different types of 
sham acupuncture and different types of no acupuncture control group. Three comparisons of sham acupuncture were 
investigated: penetrating needle vs both non-penetrating needle and non-needle sham; non-penetrating needle vs non-
needle sham; and the use of true acupuncture points vs non-acupuncture points among trials using non-penetrating or 
non-needle sham. For sham arms using penetrating needles, there was also a comparison done between the use of deep 
needle penetration and shallow needle penetration. We entered the effect size and standard error for each trial into a 
meta-regression along with the type of sham acupuncture used in that trial. For this analysis, smaller effect sizes indicate 
a smaller difference in effect between verum acupuncture and sham acupuncture, implying that the type of sham 
acupuncture used is more active and therefore more similar to verum acupuncture. For the analysis of acupuncture 
effect relative to no acupuncture control group, we used meta-regression to compare the effects of trials using no 
acupuncture control groups characterized as high intensity, usual care, or low intensity. We also repeated our prior 
analyses exploring possible effects of publication bias and exploring difference between sham acupuncture and no 
treatment. 
Results 
Systematic Review 
Our systematic review93 was updated to include trials published after November 2008 and before December 31, 2015. 
We identified 75 additional RCTs, of which 13 were eligible (Figure 1). These 13 studies include four trials19, 56, 75, 85 
included as summary data only in a sensitivity analysis in our first report.
Page 6 of 47
7 
 
Data Extraction and Quality Assessment 
Individual patient data for 2,905 patients were received from 10 of these 13 studies and included patients from the 
United States, Australia, China, Germany and the UK. For one of the three studies for which we did not receive data, the 
statisticians involved in the RCT failed to respond to repeated enquiries despite approval for data sharing being obtained 
from the principal investigator. For the other two studies, the trial authors were contacted and invited to participate but 
we received no further response. These three studies were included in the analysis as summary data only using the 
published estimates of effect size.31, 70, 75 Two trials from the original systematic review for which data were not received 
were also included as summary data in these analyses.23, 74  
A total of 20,827 patients were included in the total 39 trials (Table 1). The trials comprised 25 comparisons with 16,041 
patients of acupuncture and no acupuncture control, and 26 comparisons with 7,237 patients of acupuncture and sham 
acupuncture control. Of the trials on musculoskeletal pain, most had an eligibility criterion of a minimum 3 or 6 months 
pain duration. Amongst those for which individual patient data on chronicity were available, the median duration was 4 
years (quartiles: 1.1 years, 10 years). There were two trials for which the time period between first symptom and 
evaluation of outcome could theoretically have been less than three months based on eligibility criteria and timing of 
assessment. For Irnich et al., the duration of disease was “4 – 52 weeks” for 19% of patients and longer than one year for 
the remainder.41 In the case of Kleinhenz et al., no data were provided on chronicity, however, the indication was 
rotator cuff tendinitis, which is rarely treated in the acute phase.52 We conclude that all but a trivial proportion of 
patients included in the analysis would have met the conventional definition of chronic pain, that is, pain lasting at least 
3 to 6 months. Six sham RCTs were determined to have an intermediate likelihood of bias from unblinding.13, 26, 41, 49, 59, 103 
In one trial, two types of sham acupuncture were used, although only one type (non-needle sham acupuncture) was 
found to have an intermediate likelihood of bias from unblinding.103 One trial (Hinman et al.) was determined to have a 
sham acupuncture arm with a high likelihood of bias from unblinding.39 This trial was excluded from the main analyses 
comparing acupuncture to sham acupuncture, but a sensitivity analysis including this trial was performed. None of the 
10 new trials included in this analysis had dropout rates of higher than 25%. 
Meta-analysis 
Forest plots for acupuncture against sham acupuncture and against no acupuncture control are shown separately for 
each of the 4 pain conditions in Figure 2 and Figure 3. Fixed effects weights are reported in Figures 2 and 3; forest plots 
with random effects weights reported are presented in Figures S1 and S2 of the supplementary materials. Meta-analytic 
statistics are shown in Table 2. Consistent with the results of the originally published meta-analysis, acupuncture is 
found to be statistically superior to control for all analyses (p < 0.001). Effect sizes in the updated analyses are similar to 
those in the original analyses, with effect sizes changing by 0.02 or less for most comparisons. Effect sizes are close to 
0.5 in comparison to no acupuncture control and 0.2 for comparisons with sham. To illustrate these effect sizes in more 
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clinically applicable terms, if baseline pain score in a typical RCT was 60 on a scale of 0-100, with a standard deviation of 
25, follow-up scores might be 43 in a no acupuncture control group, 35 in a sham acupuncture group, and 30 among 
true acupuncture patients. If response were defined as a pain reduction of 50% or more, response rates would be 
approximately 30%, 42.5% and 50%, respectively. Also in keeping with the original analyses, significant heterogeneity 
was found in 5 out of 7 comparisons. Significant heterogeneity remained for sham-controlled musculoskeletal pain and 
osteoarthritis (p=0.001 and p<0.001, respectively) even after excluding the outlying Vas et al. trials. There was also 
significant heterogeneity for all indications in the comparison of acupuncture with no acupuncture control. 
Heterogeneity is further explored below (“Modifiers of Trial Outcome”).   
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Sensitivity Analyses 
Prespecified sensitivity analyses are also shown in Table 2. The exclusion of the RCTs by Vas et al.89-91 repeats our prior 
finding that the effect sizes for comparison with sham are similar for musculoskeletal pain, osteoarthritis and chronic 
headache. However, there are now sufficient trials for a meta-analysis of shoulder pain trials without inclusion of Vas et 
al.90 and the effect size for this indication is clearly much greater. There is also a large effect size for sham controlled 
neck pain trials when these are analyzed separately from back pain. Most other sensitivity analyses had little impact on 
the main findings. Analyses incorporating assessment of patient blinding, missing data or trials without individual patient 
data, all had very similar results to the primary analysis. As the primary outcome included in the analysis was the 
outcome specified by the trial authors, we also performed a sensitivity analysis restricted to a single endpoint (pain 
intensity) at a fixed follow-up time (2 – 3 months after randomization). Results were again very similar apart from sham-
controlled trials of musculoskeletal pain (Table 3), where effect size decreased from 0.30 to 0.13, but this appears to be 
attributable to there being only 5 out of 11 trials that measured pain intensity at 2-3 months, and the trials excluded 
happened to be those with the larger effect sizes.  
We combined all trials into one meta-analysis for all indications to assess the possible effect of publication bias. As in the 
original analyses, we found some evidence that smaller studies had larger effect sizes for the sham comparison 
(p=0.024), but not for the no acupuncture comparisons (p=0.75). No significant asymmetry was seen after excluding the 
Vas trials and shoulder pain trials from the sham comparison (N=21, p=0.13), and also when excluding any trials with 
fewer than 100 patients (N=21, p=0.069). We found that the difference between acupuncture and control would 
become non-significant only if there were 51 and >100 unpublished trials with 100 patients and effect sizes in favor of 
control of 0.25 SD for sham and no acupuncture control respectively.  
We also repeated our exploratory analysis comparing sham control with no acupuncture control. In a meta-analysis of 
12 RCTs that had both sham and no acupuncture control arms, the effect sizes for sham were 0.39 (95% CI 0.33, 0.45) 
and 0.45 (95% CI 0.29, 0.61) for fixed and random effects, respectively (p<0.0001 for tests of both effect and 
heterogeneity). 
Modifiers of trial outcome 
In addition to updating the primary analyses, we also updated previously published analyses on how characteristics of 
the acupuncture and control interventions influence trial outcomes. Trial-level and patient-level characteristics are 
found in Tables 4 and 5, respectively. 
 
Acupuncture Characteristics Analysis 
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We updated previously reported analyses examining whether characteristics of acupuncture treatment modified the 
effect of acupuncture relative to control. These analyses include both trial-level analysis, based on characteristics 
described in the study protocol, and patient-level analyses, based on data related to the individual patient. The results 
are shown in Table 6. We did not find any obvious association between trial outcome and characteristics such as the 
style of acupuncture (Traditional or Western), use of fixed versus individualized point selection or the use of electrical 
stimulation. The only clear finding was a dose-response effect to number of acupuncture treatments in trials with a no 
acupuncture control group (increase in effect size of 0.10 per five sessions, 95% CI -0.01, 0.21, p=0.001). 
Sham Acupuncture Control Analysis  
We also updated a previously published analysis looking at the effects of acupuncture relative to different types of sham 
acupuncture and no acupuncture control groups. Differences in effect between acupuncture and the different sham 
acupuncture groups are found in Table 7. The largest difference in effect between acupuncture and sham acupuncture 
was seen in trials using non-penetrating needles, while the smallest difference was seen in trials using needle 
penetration. Significant differences were found between trials using penetrating needle sham and those trials that used 
non-penetrating or non-needle sham (difference in SD -0.30, 95% CI -0.60, -0.00, p=0.047), although this result was 
sensitive to the exclusion of the outlying Vas trials (difference in SD -0.07, 95% CI -0.24, 0.10, p=0.4, Table 8), two of 
which used non-penetrating controls.   
No Acupuncture Control Analysis 
In addition to updating the analysis comparing types of sham acupuncture control, we also updated the analysis 
comparing types of no acupuncture control. We updated the categorization of no acupuncture control groups, and 
categorized trials as having a high intensity, usual care, or low intensity control group. In a “high intensity” control 
group, patients received a specified course of protocol-guided treatment. For instance, the UK APEX trial by Foster et 
al.33 is considered a high intensity control because patients were randomized to receive a course of individualized, 
supervised physical therapy plus acupuncture vs. physical therapy alone. In a trial with “usual care” control, patients are 
able to access whatever care they might reasonably receive outside of the study. As an example, in the UK NHS study, 
patients were randomized to "use" vs. "avoid" acupuncture and could receive whatever other treatments were offered 
to them.95 A control group was defined as “low intensity” if patients were not allowed to receive certain treatments that 
might otherwise be available. For instance, the Acupuncture Randomized Trials for low back pain and osteoarthritis 
limited treatment of pain in the control group to oral nonsteroidal anti-inflammatory drugs, excluding other types of 
treatment, such as steroids and other classes of analgesics.11, 108  Trials were assessed and assigned a control group type 
by three collaborators, with disagreements resolved by consensus. One trial was excluded from this analysis as there 
was a reasonable argument that it involved active control, prespecified to be excluded.26  Differences in effect between 
acupuncture and no acupuncture control groups are presented in Table 7. Significant differences were found between 
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acupuncture and control for all types of no acupuncture control group. Notably, however, in trials that had high intensity 
control groups, acupuncture had smaller effect sizes compared to those with low intensity controls groups (difference -
0.81, 95% CI -1.26, -0.36, p=0.0004); similarly in trials with usual care control acupuncture had smaller effect sizes than 
trials with a low intensity control group (difference in SD -0.65, 95% CI -0.98, -0.31, p=0.0002, Table 8).  
 
Time Course of Acupuncture Effects Analysis 
We updated a previously published analysis assessing change in the effects of acupuncture over time relative to sham 
acupuncture and no acupuncture control69. Number of weeks of acupuncture treatment and the time points used in this 
analysis are reported in Table 9. A total of 14 trials and 4,124 patients were included in the analysis of acupuncture vs no 
acupuncture control. The fixed-effects estimate for the between-group comparison of acupuncture vs no acupuncture 
controls showed a decrease in the effect size of acupuncture of 0.019 SD per 3 months (95% CI -0.041, 0.003, p=0.096, 
p=0.011 for heterogeneity, Figure 4a). Given a difference between acupuncture and no acupuncture control of around 
0.5 SD, this is equivalent to about a 15% decrease in acupuncture effect relative to control at 1 year after randomization, 
which was usually between 9 and 10 months after the end of treatment. In the analysis of acupuncture vs sham 
acupuncture, a total of 21 trials and 6,276 patients were included. There was a non-significant decrease of 0.012 SD per 
3 months in acupuncture relative to sham acupuncture (95% CI -0.035, 0.011, p=0.3, Figure 4b), about a 25% decrease in 
acupuncture effect at 1 year after randomization. Significant heterogeneity among trials was seen (p<0.0001). The 
previous analysis found that the decrease in effect of acupuncture relative to sham was driven by the decrease in neck 
pain trials (a decrease of 0.587 SD per 3 months, 95% CI -0.767, -0.406, p<0.0001). We also analyzed the change in 
acupuncture relative to sham excluding these trials and found a non-significant decrease of -0.003 SD per 3 months (95% 
CI -0.026, 0.020, p=0.8) with no significant heterogeneity among trials (p=0.12). Hence almost all the decrease in 
acupuncture effects in this analysis seems attributable to neck pain.  
As a sensitivity analysis, we repeated the analyses including only trials that found a significant difference between 
acupuncture and control, as trials that showed no difference between groups cannot show a reduction in acupuncture 
effects over time. Nine trials with 2,997 patients were included in this analysis for the comparison between acupuncture 
and no acupuncture controls. A smaller and still non-significant decrease in the effect of acupuncture was found (-0.008 
SD per 3 months, 95% CI -0.034, 0.018, p=0.5) and heterogeneity between trials was reduced (p=0.082). None of the 
newly included trials showed a significant effect of acupuncture vs sham and so this analysis of sham-controlled trials 
with a significant effect contains the same 7 trials and 1,450 patients and has the same results as reported in the original 
publication (-0.049 SD per 3 months, 95% CI -0.086, -0.013, p=0.008, heterogeneity p<0.0001). 
Page 11 of 47
12 
 
Discussion 
We updated an individual patient data meta-analysis of high-quality trials of acupuncture for chronic pain with seven 
additional years of data. An additional 10 studies were included with nearly 3,000 patients. In total, our analyses include 
39 studies and 20,827 patients. The results confirm and strengthen prior key findings that acupuncture has a clinically 
relevant effect compared to no acupuncture control. Moreover, we confirmed that, although the effects of acupuncture 
are not completely explicable in terms of placebo effects, factors other than the specific effects of needling at correct 
acupuncture point locations are important contributors to acupuncture treatment benefit. Effects of acupuncture 
appear to persist over at least a 12 month period.  
Heterogeneity continues to be an obvious aspect of our findings, with the results of trials varying by more than would be 
expected by chance. We have presented data that heterogeneity is predominately driven by differences between 
control groups rather than by differences between acupuncture treatment characteristics. We did not find any obvious 
differences between the results of trials depending on treatment characteristics such as style of acupuncture, duration 
of treatment sessions or training of acupuncturists. By contrast, we found evidence that effect sizes of acupuncture 
were smaller for sham-controlled trials with penetrating needles and for no acupuncture control trials where patients 
received high intensity care (e.g. a trial of acupuncture plus physical therapy vs. physical therapy alone).  In some cases, 
heterogeneity was also driven by a set of outlying trials with large effect sizes. We have presented these analyses with 
and without the outlying trials to provide all necessary information for interpreting these results and drawing 
conclusions. 
Another novel finding is the higher than average effects of acupuncture on upper body musculoskeletal pain. We now 
have sufficient data to conduct a meta-analysis for neck pain and for shoulder pain, even after exclusion of outlying 
trials. The effect sizes versus sham, 0.57 for shoulder and 0.83 for neck pain, were much larger than seen for low back 
pain, osteoarthritis and headache, although we also saw evidence that treatment benefits did not persist for neck pain.  
Since publication of our results, there has been no substantive critique of our methodology in the peer-reviewed 
literature. The main issue under discussion seems to be whether the effect size of acupuncture is clinically relevant94, 
specifically, whether clinical relevance is determined by the comparison with no acupuncture control or by comparison 
with sham. We have previously argued in favor of the former, on the grounds that the clinical decision made by a 
referring clinician in discussion with their patient is not between acupuncture and sham but between acupuncture and 
no acupuncture.  Our argument is given the context of the excellent safety profile of acupuncture66, evidence that the 
non-specific effects of acupuncture are particular to acupuncture and are not easily reproduced46, 54 and evidence 
provided here and elsewhere9 that some interventions used as sham acupuncture may be physiologically active.  
It is also illustrative to compare our results to those of other interventions routinely used in clinical practice. For 
instance, in one meta-analysis of non-steroidal anti-inflammatory drugs (NSAIDs) for osteoarthritis of the knee, the 
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effect size for NSAIDs vs placebo for trials that did not preselect NSAID responders was 0.23;10 for chronic low back pain, 
the effect size for NSAIDs is < 0.2029.   
We find several implications for research. In terms of the methodology of subsequent acupuncture trials for chronic 
pain, we find that the balance of evidence is to give a higher dose of acupuncture in terms of a greater number of 
treatments in trials without sham control. Although the nature of the control group in trials will naturally be driven by 
the research question, investigators should be aware of the evidence that control arms that incorporate a relatively 
intense level of intervention, such as when acupuncture is added into an intensive rehabilitation regimen, tend to lead 
to smaller effect sizes, as do sham controls that involve needle penetration.  Further research is warranted on whether 
acupuncture is particularly effective for upper body musculoskeletal pain. An associated hypothesis is whether there are 
subtypes of other chronic pain indications that have differential response to acupuncture. It would naturally be ideal to 
know before referring a patient for treatment whether, say, the type of back pain they are experiencing is one that 
would be amenable to treatment with acupuncture. We will also repeat our prior call for research on how best to 
incorporate acupuncture into the multidisciplinary care of chronic pain patients. 
In terms of implications for clinical practice, we have confirmed that acupuncture has a clinically relevant, persistent 
effect on chronic pain that is not completely explained by placebo effects. Referral for a course of acupuncture 
treatment is therefore a reasonable option for a patient with chronic pain. 
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. 
Figure 2. Forest plots for the comparison of acupuncture with no-acupuncture control. There were fewer than 3 trials for 
shoulder pain, so no meta-analyses were performed. Weights reported are fixed-effects weights calculated using 
inverse-variance weighting. 
Figure 3. Forest plots for the comparison of true and sham acupuncture. Weights reported are fixed-effects weights 
calculated using inverse-variance weighting. 
Figure 4. Forest plot showing the difference in pain change scores between acupuncture and no acupuncture control 
groups (a) and between acupuncture and sham acupuncture groups (b) over time. A coefficient of 0.01 means that the 
difference between acupuncture and control increases by 0.01 standard deviations for each 3 months following the end 
of treatment. 
Supplementary Materials 
Figure S1. Forest plots for the comparison of acupuncture with no-acupuncture control. There were fewer than 3 trials 
for shoulder pain, so no meta-analyses were performed. Weights reported are random-effects weights calculated using 
the DerSimonian and Laird method. 
Figure S2. Forest plots for the comparison of true and sham acupuncture. Weights reported are random-effects weights 
calculated using the DerSimonian and Laird method. 
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Table 1. Characteristics of included studies 
Indication (n=44) Pain Type Control Group Primary Outcome 
Measure 
Time Point 
Chronic headache 
(n=9) 
Migraine (n=3)26, 59, 63, 
tension-type 
headache (n=3)23, 28, 
71, both31, 43, 95 (n=3) 
Sham control (n=5)26, 
28, 59, 63, 71 
No acupuncture 
control (n=7); 
ancillary care (n=2)23, 
31; usual care (n=4)43, 
63, 71, 95; guideline care 
(n=1)26 
Severity score (n=2)23, 
95; days with 
headache (n=3)28, 43, 
71; days with migraine 
(n=2)26, 59; days with 
moderate-to-severe 
pain (n=1)63; Migraine 
Disability Assessment 
(MIDAS) (n=1)31 
1 mo (n=1)23 
2 mo (n=1)31 
3 mo (n=3)43, 63, 71 
4 mo (n=1)59 
6 mo (n=2)26, 28 
12 mo (n=1)95 
Nonspecific 
musculoskeletal pain 
(back and neck) 
(n=18) 
Back (n=12)11, 13, 18, 19, 
36, 40, 48, 49, 74, 87, 102, 111; 
neck (n=6)41, 67, 79, 91, 
104, 109 
Sham control 
(n=10)11, 13, 19, 36, 41, 48, 
49, 74, 91, 104; 
No acupuncture 
control (n=12); 
Ancillary care (n=3)40, 
74, 102; usual care 
(n=7)11, 19, 67, 79, 87, 109, 
111; non-specific 
advice (n=1)18; 
guideline care (n=1)36 
VAS (n=7)11, 13, 41, 49, 74, 
91, 104; Roland Morris 
Disability 
Questionnaire (n=3)18, 
19, 48; Northwick Park 
Neck Pain 
Questionnaire (n=2)67, 
79; SF-36 Bodily pain 
(n=2)87, 102;  Hannover 
Functional 
Questionnaire 
(n=1)111; Von Korff 
pain score (n=1)36; 
Oswestry Disability 
Index (n=1)40 
1 mo (n=4)41, 49, 91, 104  
2 mo (n=3)11, 18, 19  
3 mo (n=5)48, 74, 79, 109, 
111  
4 mo (n=1)102 
6 mo (n=2)36, 40  
8 mo (n=1)13  
12 mo (n=1)67 
24 mo (n=1)87  
Osteoarthritis (n=13)  Sham control (n=10)8, 
16, 33, 39, 70, 80, 85, 89, 103, 108 
No acupuncture 
control (n=10); 
ancillary care (n=3)33, 
70, 80; usual care 
(n=5)39, 56, 85, 108, 110; 
nonspecific advice 
(n=2)8, 107 
WOMAC (n=5)16, 56, 70, 
108, 110; WOMAC Pain 
subscore (n=4)8, 33, 80, 
89;  Oxford Knee score 
questionnaire 
(n=1)107; VAS103 (n=1); 
knee pain (0-10) 
(n=1)39; Joint-specific 
Multidimensional 
Assessment of Pain 
(n=1)85 
1 mo (n=1)103 
2 mo (n=3)70, 107, 108 
3 mo (n=6)16, 39, 56, 85, 
89, 110  
6 mo (n=3)8, 33, 80  
Shoulder pain (n=4)  Sham control (n=4)35, 
52, 75, 90  
No-acupuncture 
control (n=1); 
ancillary care (n=1)75  
Constant-Murley 
score (n=2)52, 90; VAS 
(n=2)35, 75 
1 mo (n=2)52, 90  
6 mo (n=2)35, 75  
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Table 2. Primary Analyses, N=44 trials. Acupuncture is superior to control at p<0.001 except where indicated 
  Sham No acupuncture control 
Analysis Indication No. of 
studies 
FE (95% CI) Heterogeneity 
p-value 
RE (95% CI) No. of 
studies 
FE (95% CI) Heterogeneity 
p-value 
RE (95% CI) 
Main Analysis Non-specific 
musculoskeletal pain 
10 0.30 (0.21, 0.38) p<0.001 0.49 (0.16, 0.81) 12 0.54 (0.50, 0.57) p<0.001 0.50 (0.38, 0.63) 
Osteoarthritis 9 0.24 (0.17, 0.31) p<0.001 0.45 (0.15, 0.75) 10 0.63 (0.56, 0.69) p<0.001 0.74 (0.46, 1.01) 
Chronic headache 5 0.16 (0.08, 0.25) p=0.4 0.16 (0.08, 0.25) 7 0.44 (0.39, 0.48) p<0.001 0.56 (0.35, 0.76) 
Shoulder 4 0.57 (0.44, 0.69) p=0.4 0.57 (0.44, 0.69) 0 No trials   
Exclusion of Vas 
trials 
Non-specific 
musculoskeletal pain 
9 0.19 (0.11, 0.28) p=0.001 0.31 (0.13, 0.48)     
Osteoarthritis 8 0.18 (0.10, 0.25) p<0.001 0.35 (0.07, 0.62)     
Shoulder 3 0.58 (0.42, 0.74) p=0.2 0.61 (0.40, 0.81)     
Separate pain 
types 
Back pain 7 0.17 (0.07, 0.26) p<0.001 0.30 (0.08, 0.52) 9 0.46 (0.41, 0.50) p<0.001 0.52 (0.37, 0.67) 
Neck pain 3 0.83 (0.64, 1.01) p<0.001 0.82 (-0.11, 1.75)     
Excluding trials 
with 
summary data only 
Non-specific 
musculoskeletal pain 
9 0.27 (0.19, 0.35) p<0.001 0.44 (0.11, 0.78) 11 0.53 (0.50, 0.56) p<0.001 0.45 (0.33, 0.57) 
Osteoarthritis 8 0.19 (0.12, 0.26) p<0.001 0.26 (0.04, 0.48) 9 0.59 (0.52, 0.65) p<0.001 0.59 (0.37, 0.82) 
Chronic headache     5 0.43 (0.38, 0.47) p<0.001 0.44 (0.24, 0.64) 
Shoulder 3 0.62 (0.46, 0.77) p=0.4 0.62 (0.46, 0.77)     
Excluding trials 
with possible bias 
due to blinding 
Non-specific 
musculoskeletal pain 
7 0.28 (0.19, 0.37) p<0.001 0.51 (0.09, 0.93)     
Osteoarthritis 9 0.23 (0.16, 0.31) p<0.001 0.44 (0.13, 0.75)     
Chronic headache* 3 0.15 (0.03, 0.26) p=0.15 0.12 (-0.05, 0.29)     
Including trials with 
high likelihood of 
bias due to blinding 
Osteoarthritis 10 0.23 (0.17, 0.30) p<0.001 0.42 (0.14, 0.70)     
Multiple 
imputation 
Non-specific 
musculoskeletal pain 
10 0.29 (0.21, 0.37) p<0.001 0.49 (0.16, 0.81) 12 0.54 (0.50, 0.57) p<0.001 0.51 (0.38, 0.63) 
Osteoarthritis 9 0.24 (0.17, 0.31) p<0.001 0.45 (0.15, 0.75) 10 0.63 (0.57, 0.70) p<0.001 0.74 (0.46, 1.01) 
Chronic headache 5 0.17 (0.08, 0.25) p=0.4 0.17 (0.08, 0.25) 7 0.44 (0.40, 0.49) p<0.001 0.55 (0.35, 0.75) 
Shoulder 4 0.56 (0.44, 0.69) p=0.4 0.56 (0.44, 0.69)     
Excluding trials 
where both 
acupuncture and 
control groups 
received additional 
treatments 
Non-specific 
musculoskeletal pain 
    10 0.54 (0.51, 0.57) p<0.001 0.54 (0.40, 0.67) 
Osteoarthritis 4 0.21 (0.11, 0.31) p=0.081 0.22 (0.07, 0.38) 7 0.70 (0.62, 0.78) p<0.001 0.70 (0.47, 0.93) 
Chronic headache     5 0.43 (0.38, 0.47) p<0.001 0.44 (0.24, 0.64) 
Shoulder 3 0.58 (0.42, 0.74) p=0.2 0.61 (0.40, 0.81)     
*p=0.015  
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Table 3. Sensitivity analyses including only pain endpoints measured between 2 and 3 months after randomization. 
  Sham No acupuncture control 
Analysis Indication No. of 
studies 
FE (95% CI) Heterogeneity 
p-value 
RE (95% CI) No. of 
studies 
FE (95% CI) Heterogeneity 
p-value 
RE (95% CI) 
Main 
Analysis 
Non-specific 
musculoskeletal pain 
5 0.13 (0.01, 0.25) p=0.005 0.23 (-0.03, 0.49) 9 0.60 (0.56, 0.64) p<0.0001 0.47 (0.34, 0.61) 
Osteoarthritis 7 0.31 (0.23, 0.39) p<0.0001 0.69 (0.24, 1.14) 9 0.73 (0.66, 0.80) p<0.0001 0.88 (0.61, 1.15) 
Chronic headache 5 0.14 (0.06, 0.22) p=0.4 0.14 (0.06, 0.22) 7 0.43 (0.38, 0.47) p<0.0001 0.45 (0.27, 0.63) 
Shoulder 2 No meta-analysis       
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Table 4. Trial-level acupuncture characteristics, N=39. Counts for point prescription sum to 40 because one trial had two 
acupuncture groups, with each group receiving acupuncture based on a different point prescription. 
Style of Acupuncture  
    Combination of traditional Chinese and Western 9 (23%) 
    Traditional Chinese techniques 23 (59%) 
    Western 7 (18%) 
Point Prescription  
    Fixed needle formula 9 (23%) 
    Flexible formula 18 (45%) 
    Individualized 13 (33%) 
Location of needles  
    Both Local and Distal Points 37 (95%) 
    Distal Points Only 2 (5.1%) 
Electrical stimulation allowed 11 (28%) 
Manual stimulation allowed 36 (92%) 
Moxibustion allowed 6 (15%) 
Other Adjunctive Therapies Allowed 8 (21%) 
De Qi attempted (N=35) 33 (94%) 
Acupuncture-specific patient practitioner interactions 16 (40%) 
Minimum years of experience required  
    No requirement specified (0 years) 14 (36%) 
    6 months to 2 years 7 (18%) 
    3-4 years 13 (33%) 
    5-9 years 3 (7.7%) 
    10 years 2 (5.1%) 
Maximum number of sessions  
    1-5 3 (7.7%) 
    6-10 19 (49%) 
    11-15 12 (31%) 
    16-20 1 (2.6%) 
    21-25 2 (5.1%) 
    26-30 2 (5.1%) 
Frequency of sessions (mean number of sessions per week)  
    0.88 1 (2.6%) 
    1 19 (49%) 
    1.43 1 (2.6%) 
    1.5 7 (18%) 
    1.67 1 (2.6%) 
    2 9 (23%) 
    5 1 (2.6%) 
Mean duration of sessions, rounded to whole numbers (N=34)  
    15-19 minutes 1 (2.9%) 
    20-24 minutes 11 (32%) 
    25-29 minutes 6 (18%) 
    30+ minutes 16 (47%) 
Mean number of needles used (N=33)  
    1-4 3 (9.1%) 
    5-9 11 (33%) 
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    10-14 12 (36%) 
    15-20 7 (21%) 
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Table 5. Patient-level acupuncture characteristics, n=20,827. 
Number of Sessions  
    0 441 (2.1%) 
    1-5 515 (2.5%) 
    6-10 8003 (38%) 
    11-15 2065 (10%) 
    16-20 40 (0.2%) 
    21-30 15 (<0.1%) 
    Missing 1989 (10%) 
    Not reported 7759 (37%) 
Average Session Duration  
    2-15 163 (0.8%) 
    15-30 2668 (13%) 
    31-45 377 (1.8%) 
    46-60 25 (0.1%) 
    60+ 1 (<0.1%) 
    Missing 896 (4.3%) 
    Not reported 16697 (80%) 
Average Number of Needles  
    2-5 22 (0.1%) 
    6-10 910 (4.4%) 
    11-15 762 (3.7%) 
    16-20 825 (4.0%) 
    21-25 199 (1.0%) 
    26+ 30 (0.1%) 
    Missing 1621 (7.8%) 
    Not reported 16458 (79%) 
Age of Physician/Acupuncturist  
    30-35 298 (1.4%) 
    36-40 2119 (10%) 
    41-45 2630 (13%) 
    46-50 2407 (12%) 
    51-55 1701 (8.2%) 
    56-60 872 (4.2%) 
    60+ 303 (1.5%) 
    Missing 368 (1.8%) 
    Not reported 10129 (49%) 
Physician/Acupuncturist Sex  
    Female 3626 (17%) 
    Male 7002 (34%) 
    Missing 70 (0.3%) 
    Not reported 10129 (49%) 
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Table 6. Results of univariate meta-regression analyses for the effect of acupuncture characteristics on acupuncture effect. β is an estimate of the change in the 
effect of acupuncture in terms of standardized difference compared to controls for each characteristic; a positive β indicates a larger effect of acupuncture 
compared to controls for trials. N is number of trials. The number of patients in the analysis and number of patients in included trials are given in parentheses 
where applicable. 
 Sham acupuncture No acupuncture control 
 N β 95% CI p value N β 95% CI p value 
Style of acupuncture 25    25    
    Some TCM vs. Western only  -0.00 -0.49, 0.48 >0.9  0.10 -0.55, 0.74 0.8 
    TCM only vs. some Western  0.02 -0.38, 0.42 0.9  -0.07 -0.42, 0.28 0.7 
Point prescription 25    25    
    Fixed needle formula  Ref.  0.6  Ref.  0.075 
    Flexible formula  0.20 -0.21, 0.60   0.01 -0.45, 0.46  
    Fully individualized  -0.01 -0.75, 0.73   -0.34 -0.79, 0.10  
Electrical stimulation allowed 25 0.32 -0.11, 0.75 0.14 25 -0.12 -0.50, 0.26 0.5 
Manual stimulation allowed 25 0.26 -0.42, 0.95 0.5 25 -0.38 -0.99, 0.23 0.2 
Moxibustion allowed  No trials allowed 25 -0.32 -0.71, 0.06 0.10 
Other adjunctive treatment allowed 25 -0.04 -1.00, 0.92 0.9 25 -0.22 -0.59, 0.16 0.3 
De qi attempted 25 0.29 -0.67, 1.24 0.6 21 0.74 -0.04, 1.52 0.063 
Acupuncture-specific patient 
practitioner interactions allowed 
25 -0.03 -0.50, 0.44 0.9 25 -0.05 -0.38, 0.28 0.8 
Minimum experience required (years) 25 0.04 -0.05, 0.13 0.4 25 0.05 -0.03, 0.12 0.2 
Maximum number of sessions (per 5 
sessions) 
25 -0.01 -0.23, 0.22 0.9 25 0.01 -0.12, 0.14 0.9 
    Patient-level analysis 5 (1317/ 1377) 0.09 -0.31, 0.48 0.7 5 (8036/ 10157) 0.10 -0.01, 0.21 0.001 
    Patient-level analysis, including   
    Hinman trial 
6 (1421/1517) -0.03 -0.36, -0.30 0.9     
Frequency of sessions (per week) 25 -0.06 -0.29, 0.18 0.6 25 0.21 -0.22, 0.64 0.3 
Duration of sessions (per 5 minutes)  25 0.06 -0.13, 0.25 0.5 20 -0.06 -0.25, 0.13 0.5 
    Patient-level analysis 6 (2863/2969) 0.01 -0.08, 0.09 0.9     
Number of needles used (per 5 needles)  25 0.05 -0.17, 0.27 0.6 19 0.16 -0.05, 0.38 0.13 
    Patient-level analysis 5 (2232/2317) 0.04 -0.08, 0.16 0.5     
Age of practitioner (per 5 years)         
    Patient-level analysis     6 (9127/10550) -0.01 -0.04, 0.02 0.5 
Male practitioner         
    Patient-level analysis     6 (9384/10550) -0.07 -0.16, 0.02 0.084 
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Table 7. Differences in effect size (in SD) between acupuncture and sham acupuncture groups (N=25) and between 
acupuncture and no acupuncture control groups (N=24). Total number of sham acupuncture-controlled trials sums to 26 
because one trial had two different types of sham acupuncture control. 
Sham Acupuncture 
Type of Control Group N Effect Size (95% CI) p value 
Penetrating needle sham 11 0.17 (0.11, 0.22) <0.0001 
    Excluding B blinding grades 9 0.16 (0.09, 0.24) <0.0001 
Non-penetrating needle and non-needle 
sham 
15 0.48 (0.22, 0.74) 0.0003 
    Excluding B blinding grades 11 0.51 (0.16, 0.86) 0.004 
    Including Hinman trial 16 0.46 (0.21, 0.70) 0.0003 
    Excluding Vas trials 12 0.27 (0.10, 0.44) 0.002 
Non-penetrating needle sham 10 0.52 (0.14, 0.91) 0.007 
    Excluding Vas trials 7 0.22 (-0.05, 0.49) 0.11 
Non-needle sham 5 0.37 (0.21, 0.52) <0.0001 
    Including Hinman trial 6 0.32 (0.18, 0.46) <0.0001 
True acupuncture points (no penetrating 
needle sham) 
12 0.48 (0.15, 0.80) 0.004 
    Excluding B blinding grades 10 0.51 (0.12, 0.89) 0.010 
    Including Hinman trial 13 0.45 (0.15, 0.75) 0.003 
    Excluding Vas trials 10 0.25 (0.06, 0.44) 0.011 
Non-acupuncture points (no penetrating 
needle sham) 
3 0.52 (0.35, 0.69) <0.0001 
    Excluding Vas trials 2 0.47 (0.13, 0.81) 0.007 
 
No Acupuncture Control 
Type of Control Group N Effect Size (95% CI) p value 
High intensity 5 0.34 (0.11, 0.57) 0.003 
Usual care and low intensity 19 0.56 (0.43, 0.69) <0.0001 
Usual care 17 0.50 (0.40, 0.60) <0.0001 
Low intensity 2 1.14 (0.71, 1.58) <0.0001 
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Table 8. Differences in effect size between different types of control group. A negative effect size indicates that there is 
a smaller difference in effect between acupuncture and control for group 1 than for group 2, that is, the effect of control 
group 1 is more similar to verum acupuncture than the effect of control group 2. 
Sham Acupuncture 
Group 1 Group 2 Effect Size (95% CI) p value 
Penetrating needle sham Non-penetrating and non-needle sham -0.30 (-0.60, -0.00) 0.047 
    Excluding B blinding grades -0.33 (-0.72, 0.05) 0.088 
    Including Hinman trial  -0.28 (-0.57, 0.01) 0.061 
    Excluding Vas trials -0.07 (-0.24, 0.10) 0.4 
Non-penetrating needle sham Non-needle sham 0.13 (-0.44, 0.70) 0.6 
    Including Hinman trial  0.18 (-0.34, 0.70) 0.5 
    Excluding Vas trials  -0.18 (-0.52, 0.17) 0.3 
True acupuncture points, excluding 
penetrating needle sham 
Non-acupuncture points, excluding 
penetrating needle sham 
-0.02 (-0.70, 0.66) 0.9 
    Including Hinman trial  -0.05 (-0.71, 0.61) 0.9 
    Excluding Vas trials -0.22 (-0.75, 0.30) 0.4 
 
No Acupuncture Controls 
Group 1 Group 2 Effect Size (95% CI) p value 
High intensity Usual care and low intensity -0.23 (-0.50, 0.05) 0.11 
High intensity Low intensity -0.81 (-1.26, -0.36) 0.0004 
Usual care Low intensity -0.65 (-0.98, -0.31) 0.0002 
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Table 9. Trials with sham and no acupuncture control and time points assessed after the end of treatment 
 Sham Acupuncture No acupuncture control 
Trial Name Pain Condition Average 
Length 
of Treatment 
Time Points after End 
of Treatment 
Included in meta-
analysis 
Control patients offered 
acupuncture treatment 
(Crossover) 
Time Points after End of 
Treatment 
Included in meta-
analysis 
Carlsson 2001
13
 Low Back Pain 8 weeks Weeks 5 and 18 Yes    
Chen 2013
16
 Osteoarthritis 12 weeks End of treatment and 
week 14 
Yes    
Endres 2007
28
 Headache 6 weeks End of treatment and 
weeks 7 and 20 
Yes    
Guerra de Hoyos 
2004
35
 
Shoulder 8 weeks Weeks 5 and 18 Yes    
Irnich 2001
41
 Neck 3 weeks Weeks 1 and 10 Yes    
Kennedy 2008
48
 Low Back Pain 5 weeks End of treatment and 
week 7 
Yes    
Kerr 2003
49
 Low Back Pain 6 weeks None No    
Kleinhenz 1999
52
 Shoulder 4 weeks End of treatment No    
Li 2012
59
 Migraine 4 weeks End of treatment and 
week 4 
Yes    
Vas 2004
89
 Osteoarthritis 12 weeks Week 1 No    
Vas 2006
91
 Neck 3 weeks Weeks 1 and 25 Yes    
Vas 2008
90
 Shoulder 3 weeks Weeks 1 and 10 Yes    
White 2004
104
 Neck 4 weeks End of treatment and 
weeks 1 through 8 
Yes    
White 2012
103
 Osteoarthritis 4 weeks End of treatment and 
week 1 
Yes    
Berman 2004
8
 Osteoarthritis 26 weeks End of treatment No No End of treatment No 
Brinkhaus 2006
11
 Low Back Pain 8 weeks End of treatment and 
weeks 18 and 44 
Yes At 8 weeks End of treatment No 
Cherkin 2009
19
 Low Back Pain 7 weeks Weeks 1, 19 and 45 Yes No Weeks 1, 19 and 45 Yes 
Diener 2006
26
 Migraine 6 weeks End of treatment and 
weeks 7 and 20 
Yes No End of treatment and 
weeks 7 and 20 
Yes 
Foster 2007
33
 Osteoarthritis 3 weeks Weeks 3, 23 and 49 Yes No Weeks 3, 23 and 49 Yes 
Haake 2007
36
 Low Back Pain 6 weeks End of treatment and 
weeks 7 and 20 
Yes No End of treatment and 
weeks 7 and 20 
Yes 
Linde 2005
63
 Migraine 8 weeks End of treatment and 
weeks 4 and 16 
Yes At 12 weeks Week 4 No 
Melchart 2005
71
 Headache 8 weeks End of treatment and 
weeks 4 and 16 
Yes At 12 weeks Week 4 No 
Scharf 2006
80
 Osteoarthritis 6 weeks Weeks 7 and 20 Yes No Weeks 7 and 20 Yes 
Suarez-Almazor 
2010
85
 
Osteoarthritis 6 weeks End of treatment and 
week 7 
Yes No Week 7 No 
Witt 2005
108
 Osteoarthritis 8 weeks End of treatment and 
weeks 18 and 44 
Yes At 8 weeks End of treatment No 
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Cherkin 2001
18
 Low Back Pain 10 weeks   No End of treatment and 
week 42 
Yes 
Hinman 2014
39
 Osteoarthritis 12 weeks   No End of treatment and 
week 40 
Yes 
Hunter 2012
40
 Low Back Pain 6 weeks   No Weeks 2, 7 and 20 Yes 
Jena 2008
43
 Headache 12 weeks   At 12 weeks All measurements after 
crossover 
No 
Lansdown 2009
56
 Osteoarthritis 10 weeks   No Weeks 3 and 42 Yes 
MacPherson 
2015
67
 
Neck 16 weeks   No Weeks 10 and 36 Yes 
Thomas 2006
87
 Low Back Pain 12 weeks   No Weeks 1, 40 and 92 Yes 
Salter 2006
79
 Neck 12 weeks   No Week 1 No 
Vickers 2004
95
 Headache 6 weeks   No Weeks 1 and 40 Yes 
Weiss 2013
102
 Low Back Pain 4 weeks   No End of treatment and 
week 13 
Yes 
Williamson 
2007
107
 
Osteoarthritis 6 weeks   No Weeks 1 and 6 Yes 
Witt 2006
109
 Neck 12 weeks   At 12 weeks All measurements after 
crossover 
No 
Witt 2006
110
 Osteoarthritis 12 weeks   At 12 weeks All measurements after 
crossover 
No 
Witt ARC 2006
111
 Low Back Pain 12 weeks   At 12 weeks All measurements after 
crossover 
No 
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Figure 1 2017-10-24_bestsetConverted.png 
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Figure 2 No Acupuncture Control.eps 
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Figure 3 Sham Control.eps 
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Figure 4a Time Course No Acupuncture.eps 
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Figure 4b Time Course Sham.eps 
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Figure S1 No Acupuncture Control RE.eps 
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Figure S2 Sham Control RE.eps 
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